/biz/ - Business & Finance

After holding this for a year, finally SNSS is well into the green. Vecabrutinib may not have played out like SNSS Anon told me it would, but being right about the stock going up, even for the wrong reasons, is okay in my book. At least it went up eventually. My kids college fund may survive intact until they turn 18 after all.

I think I'm going to sell today. They are doing a reverse merger with a company named Viracta Therapeutics, the stock ticker is changing, and I don't really understand what's going on, and Viracta is a private company, so I can't even LARP as an analyst here. The good folks on StockTwits are still bullish though, so SNSS could still be a good buy for the biotech-inclined people among us.

As for me, I think curing cancer and such are noble goals, but I think I will stick to the the simpler things that I do understand. Like fish.